Literature DB >> 2533881

Tumour-associated proliferative responses in vitro of regional lymph nodes draining solid cancers in man.

T Mainou-Fowler1, O Eremin.   

Abstract

The proliferative responses in vitro of tumour-draining lymph node lymphocytes were evaluated against autologous colon and lung carcinoma cells. The reactivity of lymphocytes appeared to be directed against tumour-associated rather than tumour-specific antigens. The lymphocyte reactivity detected was not due to an autologous mixed lymphocyte reaction. Recombinant interleukin-2 augmented the responses detected but not their tumour specificity. Phenotypic characterisation indicated the presence of T suppressor/cytotoxic (TS/C) cells as well as natural killer (NK) cells. Only the later, however, were active in functional cytotoxicity assays. The inability to generate both tumour-specific proliferation of tumour-draining lymph node lymphocytes and tumour-specific cytotoxic killer cells may be due to the presence of suppressor cells in the regional lymph nodes; preliminary data suggest the presence of such cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2533881     DOI: 10.1007/bf01744898

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  23 in total

1.  Differences in the tumor-associated reactivity of blood lymphocytes and tumor-draining lymph node cells in sarcoma patients.

Authors:  F Vánky; J Stjernswärd; U Nilsonne
Journal:  J Natl Cancer Inst       Date:  1973-07       Impact factor: 13.506

2.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

3.  T-lymphocyte and B-lymphocyte subpopulations infiltrating human mammary carcinomas.

Authors:  O Eremin; R R Coombs; T D Prospero; D Plumb
Journal:  J Natl Cancer Inst       Date:  1982-07       Impact factor: 13.506

4.  Cell-mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigens.

Authors:  G M Mavligit; J U Gutterman; C M McBride; E M Hersh
Journal:  Natl Cancer Inst Monogr       Date:  1973-06

5.  Ly-1+2- suppressor T cells inhibit the expression of passively transferred antitumor immunity by suppressing the generation of cytolytic T cells.

Authors:  C D Mills; R J North
Journal:  Transplantation       Date:  1985-02       Impact factor: 4.939

6.  Inhibition of cytotoxicity to autologous tumor cells by the regional lymph node cells of patients with primary lung cancer.

Authors:  C Kadoyama; H Kimura; Y Yamaguchi
Journal:  Jpn J Clin Oncol       Date:  1987-03       Impact factor: 3.019

7.  Mitogen responsiveness and inhibitory activity of mesenteric lymph node cells. Conditioned medium containing T cell growth factor reverses suppressor function.

Authors:  B M Vose; R Ferguson; M Moore
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

8.  The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues.

Authors:  E A Grimm; B M Vose; E W Chu; D J Wilson; M T Lotze; A A Rayner; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

9.  Human regional tumour lymph nodes: alterations of micro-architecture and lymphocyte subpopulations.

Authors:  O Eremin; P Roberts; D Plumb; J P Stephens
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

10.  Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity.

Authors:  O Eremin; R R Coombs; J Ashby
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

View more
  1 in total

1.  Effect of essential fatty acids on circulating T cell subsets in patients with colorectal cancer.

Authors:  P Purasiri; J Ashby; S D Heys; O Eremin
Journal:  Cancer Immunol Immunother       Date:  1994-10       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.